InvestorsHub Logo
Followers 7
Posts 943
Boards Moderated 0
Alias Born 03/27/2013

Re: None

Friday, 11/10/2017 9:06:19 PM

Friday, November 10, 2017 9:06:19 PM

Post# of 178
Credit Suisse Group Boosts Puma Biotechnology Inc (PBYI) Price Target to $142.00
November 10th, 2017 •


Puma Biotechnology logoPuma Biotechnology Inc (NYSE:PBYI) had its price objective lifted by equities researchers at Credit Suisse Group from $136.00 to $142.00 in a research report issued to clients and investors on Friday. The brokerage currently has an “outperform” rating on the biopharmaceutical company’s stock. Credit Suisse Group’s target price would indicate a potential upside of 37.86% from the stock’s previous close.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PBYI News